FiercePharmaOriginal article
{"a":[{"_":"FDA solidifies CDER, CBER leadership posts as commissioner confirmation awaits","$":{"href":"/pharma/fda-solidifies-cder-cber-leadership-posts-commissioner-confirmation-awaits","hreflang":"en"}}]}
RegulatoryNeutral
AI Analysis
Summary
The FDA solidified its leadership structure by permanently appointing Michael Davis as CDER director and Karim Mikhail as CBER director. This stabilizing move comes as the agency awaits confirmation of a new FDA commissioner.
Outcome Details
Michael Davis, M.D., Ph.D. confirmed as permanent CDER director and Karim Mikhail confirmed as permanent CBER director
Importance:3/10
Sentiment:
0.00
FDALeadershipCDERCBERRegulatoryPersonnel
Related Companies
Read the original article
Published by FiercePharma on September 9, 2026 9:01 AM